WallStreetZenWallStreetZen

NASDAQ: IMMX
IMMIX Biopharma Inc Stock Ownership - Who owns IMMIX Biopharma?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have IMMIX Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gabriel S. MorrisCFO2025-12-10770$6.58
$5.07kBuy
Ilya M. RachmanCEO and Chairman2025-12-10746$6.67
$4.98kBuy
Gabriel S. MorrisCFO2025-12-08156,000$0.80
$124.80kBuy
Ilya M. RachmanCEO and Chairman2025-09-172,500$2.02
$5.05kBuy
Gabriel S. MorrisCFO2025-09-162,600$1.97
$5.12kBuy
Gabriel S. MorrisCFO2025-06-182,225$2.28
$5.07kBuy
Ilya M. RachmanCEO and Chairman2025-06-182,178$2.30
$5.00kBuy

1 of 1

IMMX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMMX insiders and whales buy or sell their stock.

IMMX Shareholders

What type of owners hold IMMIX Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Yekaterina Chudnovsky9.65%3,241,076$19.84MInsider
Ilya M. Rachman3.40%1,141,683$6.99MInsider
Carey Ng3.11%1,045,221$6.40MInsider
Jason Hsu2.81%943,000$5.77MInsider
Nancy T. Chang2.74%918,880$5.62MInsider
Vladimir P. Torchilin2.70%905,200$5.54MInsider
Sean Senn2.68%899,800$5.51MInsider
Bleichroeder LP2.53%850,000$5.20MInstitution
Vanguard Group Inc2.17%730,162$4.47MInstitution
Gabriel S. Morris0.94%315,570$1.93MInsider

1 of 3

IMMX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMMX8.24%28.87%Net BuyingNet Buying
VYGR50.66%49.34%Net Selling
SLN13.91%0.09%
ARCT87.51%12.49%Net Buying
SRZN23.62%76.38%Net BuyingNet Buying
View Top Biotech Stocks

IMMIX Biopharma Stock Ownership FAQ

Who owns IMMIX Biopharma?

IMMIX Biopharma (NASDAQ: IMMX) is owned by 8.24% institutional shareholders, 28.87% IMMIX Biopharma insiders, and 62.89% retail investors. Yekaterina Chudnovsky is the largest individual IMMIX Biopharma shareholder, owning 3.24M shares representing 9.65% of the company. Yekaterina Chudnovsky's IMMIX Biopharma shares are currently valued at $19.84M.

If you're new to stock investing, here's how to buy IMMIX Biopharma stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.